The PI3K-AKT pathway is among the most frequently activated signaling cascades in CRC (55), and its aberrant activation drives tumor growth through mechanisms such as promoting cell cycle progression and inhibiting apoptosis (55–57). This evidence concerns the gene AKT1 and neoplasm.